The National Cancer Center Hospital of the National Cancer Center (NCC) Japan serves as clinical investigational site for a Phase I clinical trial of Boron Neutron Capture Therapy (BNCT) for malignant melanoma and angiosarcoma, using the CICS-1 accelerator-based...